Market closed
Sophia Genetics/$SOPH
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Sophia Genetics
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
Ticker
$SOPH
Sector
Trading on
Industry
Health Care Technology
Headquarters
Rolle, Switzerland
Employees
430
Website
Sophia Genetics Metrics
BasicAdvanced
$270M
-
-$1.09
1.01
-
Price and volume
Market cap
$270M
Beta
1.01
52-week high
$7.37
52-week low
$2.70
Average daily volume
114K
Financial strength
Current ratio
3.798
Quick ratio
3.42
Long term debt to equity
25.722
Total debt to equity
27.904
Interest coverage (TTM)
-115.72%
Management effectiveness
Return on assets (TTM)
-22.18%
Return on equity (TTM)
-52.51%
Valuation
Price to revenue (TTM)
4.146
Price to book
2.38
Price to tangible book (TTM)
3.25
Price to free cash flow (TTM)
-5.142
Growth
Revenue change (TTM)
9.85%
Earnings per share change (TTM)
1.77%
3-year revenue growth (CAGR)
19.97%
3-year earnings per share growth (CAGR)
-3.91%
What the Analysts think about Sophia Genetics
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Sophia Genetics stock.
Sophia Genetics Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Sophia Genetics Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Sophia Genetics stock?
Sophia Genetics (SOPH) has a market cap of $270M as of February 25, 2025.
What is the P/E ratio for Sophia Genetics stock?
The price to earnings (P/E) ratio for Sophia Genetics (SOPH) stock is 0 as of February 25, 2025.
Does Sophia Genetics stock pay dividends?
No, Sophia Genetics (SOPH) stock does not pay dividends to its shareholders as of February 25, 2025.
When is the next Sophia Genetics dividend payment date?
Sophia Genetics (SOPH) stock does not pay dividends to its shareholders.
What is the beta indicator for Sophia Genetics?
Sophia Genetics (SOPH) has a beta rating of 1.01. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.